menu Search
Ermina

Ermina Description

ethinylestradiol + drospirenone

Manufacturer:

Sun Pharma Industries

Distributor:

DKT

Marketer:

DKT
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Description
Drospirenone + Ethinylestradiol (ERMINA) contains drospirenone 3 mg and ethinylestradiol 0.02 mg. Drospirenone and ethinylestradiol are progestogens and estrogens, fixed combinations. Drospirenone + Ethinylestradiol (ERMINA) is available as pink, circular, biconvex film-coated tablet debossed with "159" on one side and plain on other side.
Its chemical name is (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione. It has a molecular weight of 366.5 g/mol and a molecular formula of C24H30O3.
Ethinylestradiol is a semisynthetic alkylated estradiol with a 17-alpha-ethinyl substitution. Its chemical name is (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. It has a molecular weight of 296.41 g/mol and a molecular formula of C20H24O3.
Each film-coated tablet contains: Drospirenone, USP 3 mg, Ethinylestradiol, USP 20 mcg, Excipient q.s.
Inactive ingredients: Lactose monohydrate, corn starch, colloidal silicon dioxide, hypromellose 2910, purified water, talc, magnesium stearate and opadry II pink.